Mardi C. Dier
2016
In 2016, Mardi C. Dier earned a total compensation of $3.4M as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Non-Equity Incentive Plan | $92,874 |
| Option Awards | $1,533,984 |
| Salary | $412,775 |
| Stock Awards | $1,307,075 |
| Other | $17,783 |
| Total | $3,444,491 |
Dier received $1.5M in option awards, accounting for 45% of the total pay in 2016.
Dier also received $80K in bonus, $92.9K in non-equity incentive plan, $412.8K in salary, $1.3M in stock awards and $17.8K in other compensation.
Rankings
In 2016, Mardi C. Dier's compensation ranked 2,698th out of 14,075 executives tracked by ExecPay. In other words, Dier earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,698 out of 14,075 | 81st |
Division Manufacturing | 926 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 270 out of 1,895 | 86th |
Industry group Drugs | 196 out of 1,538 | 87th |
Industry Pharmaceutical Preparations | 149 out of 1,176 | 87th |
Source: SEC filing on April 24, 2017.
Dier's colleagues
We found three more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2016.